APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2020 FINANCIAL RESULTSBy ApyxMedical|2025-12-12T19:35:21+00:00November 9, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES UPDATES ON U.S. IDE CLINICAL STUDIESBy ApyxMedical|2025-12-12T19:35:52+00:00November 9, 2020|2020 Shareholder News, Case Study, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES TWO PEER-REVIEWED CLINICAL PUBLICATIONS EVALUATING RENUVION’S HELIUM PLASMA TECHNOLOGYBy ApyxMedical|2025-12-12T19:36:16+00:00October 20, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2020 FINANCIAL RESULTS ON NOVEMBER 9, 2020By ApyxMedical|2025-12-12T19:36:39+00:00October 1, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBERBy ApyxMedical|2025-12-12T19:37:13+00:00August 31, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2020 FINANCIAL RESULTSBy ApyxMedical|2025-12-12T19:37:38+00:00August 7, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2020 FINANCIAL RESULTS ON AUGUST 10, 2020By ApyxMedical|2025-12-12T19:37:59+00:00June 25, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES REGULATORY CLEARANCE TO MARKET AND SELL ITS HELIUM PLASMA TECHNOLOGY PRODUCTS IN FIVE NEW COUNTRIESBy ApyxMedical|2025-12-12T19:38:21+00:00June 22, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2020 FINANCIAL RESULTSBy ApyxMedical|2025-12-12T19:38:50+00:00May 11, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2020 FINANCIAL RESULTS ON MAY 11, 2020By ApyxMedical|2025-12-12T19:39:16+00:00April 7, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR OF 2019 PRELIMINARY UNAUDITED FINANCIAL RESULTS AND INTRODUCES FIRST QUARTER OF FISCAL YEAR 2020 FINANCIAL OUTLOOKBy ApyxMedical|2025-12-12T19:39:43+00:00March 16, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RESTATE PREVIOUSLY ISSUED FINANCIAL STATEMENTSBy ApyxMedical|2025-12-12T19:40:08+00:00March 16, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2019 FINANCIAL RESULTS ON MARCH 16, 2020By ApyxMedical|2025-12-12T19:40:31+00:00February 5, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FULL YEAR AND FOURTH QUARTER 2019 REVENUE RESULTSBy ApyxMedical|2025-12-12T19:40:55+00:00January 13, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES SUBJECT ENROLLMENT INITIATED IN NEW STUDY EVALUATING THE USE OF RENUVION® TECHNOLOGY IN DERMAL RESURFACING PROCEDURESBy ApyxMedical|2025-12-12T19:41:17+00:00December 3, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS THIRD QUARTER OF 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOKBy ApyxMedical|2025-12-12T19:41:43+00:00November 11, 2019|2019 Shareholder News, J-Plasma, Renuvion|
